theconservativetreehouse--2020-03-18--Mike Pence: “Now is the Time To Pull Together”…

Mike Pence : In the fight against the coronavirus , the Trump administration is not just taking a whole of government approach , but a whole of America approach .
We ’ ve worked seamlessly with state and local leaders from both political parties .
Since January , we ’ ve held 36 briefings with more than 15,000 state , local and tribal leaders from every state and territory in America .
And that is in addition to thousands of individual conversations with state , local , and tribal officials .
A vaccine for the coronavirus has already begun a @ @ @ @ @ @ @ has dramatically expanded access to telemedicine for seniors on Medicare .
And the Health and Human Services Department is collaborating with Johnson & Johnson to develop treatments for coronavirus infections , while actively soliciting proposals for other medical products to help combat the virus .
The risk of serious illness for the average American remains low .
But the risk is heavily weighted to the elderly with underlying health conditions .
Now is a critical time .
As the president said on Monday , over the next two weeks , there are actions @ @ @ @ @ @ @ to help us slow the spread of the coronavirus .
If we succeed in limiting the number of new cases , then we can dedicate more resources to the most vulnerable and save lives .
As the president said , if you or anyone in your household is sick , then please stay home .
The elderly and those with serious health conditions should also stay home and stay away from other people , even if they do not have symptoms of the coronavirus .
No one should visit a nursing home , @ @ @ @ @ @ @ to provide necessary care .
All Americans should avoid unnecessary travel , restaurants , bars , public food courts and gathering in groups of more than 10 people .
Kids should stay home from school , and Americans who do not work in our critical infrastructure — like health care or pharmaceuticals — should work from home .
It ’ s always a good idea to practice common sense to protect your health and the health of your family , but it ’ s especially important right now .
Use good hygiene .
@ @ @ @ @ @ @ frequently used surfaces like doorknobs .
Use disinfectant on frequently used items and surfaces .
Avoid touching your face .
If you have to sneeze , then use a tissue or the inside of your elbow .
These steps might seem small , but they can make a big difference for your family , your community and our country .
Stopping the spread of the coronavirus over these next two weeks can prevent many more cases in the future and even save the lives of those at risk .
The president and I @ @ @ @ @ @ @ have already pulled together in so many ways in response to this virus , just as we ’ ve always done during other challenging times in our history .
The president and I have been especially pleased to see churches and businesses come forward to help those in need .
We have personally met with leaders from the manufacturing , cruiseline , airline and tourism industries , and many more .
On a daily basis , America ’ s CEOs have been calling us to ask how they can help .
In the @ @ @ @ @ @ @ administration will continue to take strong action to protect the American people , and we will continue to build on the partnerships that we ’ ve forged with state and local governments , as well as with the scientific and business communities .
But for all of these important steps , there is no substitute for the action of the American people .
If all of us can take these important steps requested by the president over the next two weeks , then we can be confident that we will get through this @ @ @ @ @ @ @ , healthier future for America .

A message from Vice President Mike Pence…
Mike Pence: In the fight against the coronavirus, the Trump administration is not just taking a whole of government approach, but a whole of America approach.
We’ve worked seamlessly with state and local leaders from both political parties. Since January, we’ve held 36 briefings with more than 15,000 state, local and tribal leaders from every state and territory in America. And that is in addition to thousands of individual conversations with state, local, and tribal officials.
A vaccine for the coronavirus has already begun a phase 1 clinical trial. The president has dramatically expanded access to telemedicine for seniors on Medicare. And the Health and Human Services Department is collaborating with Johnson & Johnson to develop treatments for coronavirus infections, while actively soliciting proposals for other medical products to help combat the virus.
Average American at low risk
The risk of serious illness for the average American remains low. But the risk is heavily weighted to the elderly with underlying health conditions.
Now is a critical time. As the president said on Monday, over the next two weeks, there are actions that every American can and should take to help us slow the spread of the coronavirus. If we succeed in limiting the number of new cases, then we can dedicate more resources to the most vulnerable and save lives.
As the president said, if you or anyone in your household is sick, then please stay home. The elderly and those with serious health conditions should also stay home and stay away from other people, even if they do not have symptoms of the coronavirus.
No one should visit a nursing home, retirement home or long-term care facility unless to provide necessary care. All Americans should avoid unnecessary travel, restaurants, bars, public food courts and gathering in groups of more than 10 people. Kids should stay home from school, and Americans who do not work in our critical infrastructure — like health care or pharmaceuticals — should work from home.
It’s always a good idea to practice common sense to protect your health and the health of your family, but it’s especially important right now. Use good hygiene. Wash your hands, especially after touching frequently used surfaces like doorknobs.
Small steps, big impact
Use disinfectant on frequently used items and surfaces. Avoid touching your face. If you have to sneeze, then use a tissue or the inside of your elbow.
These steps might seem small, but they can make a big difference for your family, your community and our country. Stopping the spread of the coronavirus over these next two weeks can prevent many more cases in the future and even save the lives of those at risk.
The president and I are deeply proud that the American people have already pulled together in so many ways in response to this virus, just as we’ve always done during other challenging times in our history. The president and I have been especially pleased to see churches and businesses come forward to help those in need. We have personally met with leaders from the manufacturing, cruiseline, airline and tourism industries, and many more. On a daily basis, America’s CEOs have been calling us to ask how they can help.
In the weeks ahead, President Trump and this administration will continue to take strong action to protect the American people, and we will continue to build on the partnerships that we’ve forged with state and local governments, as well as with the scientific and business communities.
But for all of these important steps, there is no substitute for the action of the American people. If all of us can take these important steps requested by the president over the next two weeks, then we can be confident that we will get through this, and we will see a better, healthier future for America.
(link)


theconservativetreehouse--2020-03-18--U.S. Auto Industry Shuts Down Amid Coronavirus Struggle…

This is a big sector hit to the U.S. economy .
All of the major U.S. auto manufacturers have agreed to shut down all production facilities , through March 30th , in the latest thunder-shock to the economy .
Ford said in a statement Wednesday that its U.S. , Canadian and Mexican manufacturing facilities will be halted after Thursday evening ’ s shifts through March 30 to “ thoroughly clean and sanitize the company ’ s plants.
” DETROIT – Ford Motor Co. , General Motors and Fiat-Chrysler will close their plants due to the coronavirus ( COVID-19 ) outbreak @ @ @ @ @ @ @ work together in the coming weeks on plant restart plans as well as exploring additional protocols and procedures for helping prevent the spread of the virus , ” reads the statement from Ford .
General Motors also released a statement explaining the shutdown will be until at least March 30 .
“ GM and the UAW have always put the health and safety of the people entering GM plants first , and we have agreed to a systematic , orderly suspension of production to aid in fighting COVID-19/coronavirus , ” said GM Chairman @ @ @ @ @ @ @ it is working with the UAW to make sure all employees will be compensated .
( read more )

This is a big sector hit to the U.S. economy. All of the major U.S. auto manufacturers have agreed to shut down all production facilities, through March 30th, in the latest thunder-shock to the economy.
DETROIT – Ford Motor Co., General Motors and Fiat-Chrysler will close their plants due to the coronavirus (COVID-19) outbreak. Ford said in a statement Wednesday that its U.S., Canadian and Mexican manufacturing facilities will be halted after Thursday evening’s shifts through March 30 to “thoroughly clean and sanitize the company’s plants.”


theconservativetreehouse--2020-03-18--The Media Disconnect – White House Press Pool Focused on Political Correctness While Million of Amer

The Media Disconnect – White House Press Pool Focused on Political Correctness While Million of Americans Suffer Economic Impacts…

The entire nation is being impacted by a multitude of consequences from coronavirus ; millions of Americans concerned about lost @ @ @ @ @ possibly lost jobs ; the largest economy in the world at a near standstill ; @ @ @ @ @ rippling economic consequences yet to be properly quantified ; … .
and yet the White @ @ @ @ @ about calling COVID-19 the “ Chinese coronavirus ” ?
Amid all of the seemingly unending @ @ @ @ @ journalists , this is , yet again , reaching an all time high of stupidity @ @ @

The entire nation is being impacted by a multitude of consequences from coronavirus; millions of Americans concerned about lost work, lost wages and possibly lost jobs; the largest economy in the world at a near standstill; trillions of wealth lost and rippling economic consequences yet to be properly quantified;…. and yet the White House press pool is worried about calling COVID-19 the “Chinese coronavirus”?
Amid all of the seemingly unending and insufferable nonsense from American journalists, this is, yet again, reaching an all time high of stupidity. WATCH:
.
Nuts !


theconservativetreehouse--2020-03-19--Treasury Secretary Steven Mnuchin Explains U.S. Financial Response to Economic Impact from Chinese C

Treasury Secretary Steven Mnuchin Explains U.S. Financial Response to Economic Impact from Chinese Coronavirus…

Treasury Secretary Steven Mnuchin called-in to Maria Bartiromo earlier today to discuss the overall financial approach of the Trump administration @ @ @ @ @ Mnuchin has been working closely with House and Senate political leadership to structure the financial @ @ @ @ @ and workers inside the Main St economy .
The target date for legislation directing the @ @ @ @ @ week .
The underlying economy is strong .
The treasury response is targeted to those @ @ @ @ @ Short-term economic indicators are no longer valid .

Treasury Secretary Steven Mnuchin called-in to Maria Bartiromo earlier today to discuss the overall financial approach of the Trump administration to the COVID-19 impacts.
Mnuchin has been working closely with House and Senate political leadership to structure the financial flow needed for particular sectors and workers inside the Main St economy. The target date for legislation directing the financial relief is early next week.
The underlying economy is strong. The treasury response is targeted to those who need short-term relief. Short-term economic indicators are no longer valid.


theconservativetreehouse--2020-03-19--Former Obamacare Official Spreads Panic on MSNBC Demands All Masks Sent to New York City…

As you watch this , you start to realize the national panic hasn ’ t yet really sunk in .
@ @ @ @ @ the instability of Mr. Slavitt and how he expresses it .
Former Obamacare official Andy @ @ @ @ @ a state of panic to demand that all medical masks and equipment throughout the nation @ @ @ @ @ City ; while accusing other states , including Texas , of “ hoarding ” critical @ @ @ @ @ Administrator Craig Fugate recognizes that participating in any discussion with this level of emotional panic @ @ @ @ @ helpful , he walks off set .
WATCH : Panicked NYC resident and visibly unstable @ @ @ @ @ , is talking about medical equipment when he demands all masks and supplies be redirected @ @ @ @ @ sense of urgency .
However , imagine *if* the shortage *was* food .
Prepare yourselves @ @ @ @ @

As you watch this, you start to realize the national panic hasn’t yet really sunk in. However, think carefully about the instability of Mr. Slavitt and how he expresses it.
Former Obamacare official Andy Slavitt appears on MSNBC in a state of panic to demand that all medical masks and equipment throughout the nation be sent to New York City; while accusing other states, including Texas, of “hoarding” critical healthcare supplies.
Former FEMA Administrator Craig Fugate recognizes that participating in any discussion with this level of emotional panic is not going to be helpful, he walks off set. WATCH:
.
Panicked NYC resident and visibly unstable former ACA official Andy Slavitt, is talking about medical equipment when he demands all masks and supplies be redirected to New York with a sense of urgency. However, imagine *if* the shortage *was* food. Prepare yourselves and your family accordingly.


theconservativetreehouse--2020-03-19--FDA Speeding Clinical Trials of Chloroquine as Possible Therapeutic – FDA Commissioner Stephen Hahn

FDA Speeding Clinical Trials of Chloroquine as Possible Therapeutic – FDA Commissioner Stephen Hahn Transcript…

During the task force briefing President Trump announced authorizing to the FDA to relax regulationsto speed up clinical trials for several anti-viral remedies to treat coronavirus .
Specifically citing a therapudic drug known as chloroquine President Trump noted trials are underway and could be made available for treatment “ almost immediately.
” Now , a drug called chloroquine — and some people would add to it “ hydroxy-.
” Hydroxychloroquine .
So chloroquine or hydroxychloroquine .
Now , this is a common malaria drug .
It is also a drug used for strong arthritis .
If somebody has pretty serious @ @ @ @ @ @ @ somewhat different form .
FDA commissioner Stephen Hahn told reporters scientists still have to conduct clinical trials to see if chloroquine , hydroxychloroquine , and several other anti-viral medications are effective against coronavirus .
However , since chloroquine and hydroxychloroquine are already FDA approved to treat malaria & arthritis , they could be used to treat other conditions , including coronavirus , in an “ off label ” basis .
DR. HAHN : So , before the President nominated me and I was confirmed as Commissioner for Food and Drugs , I was @ @ @ @ @ @ @ ve sat across from countless number of patients and had to talk to them about their diagnosis and their treatment .
And one thing that was really important is to provide hope .
I have great hope for how we ’ re going to come out of this situation .
What ’ s also important is not to provide false hope , but to provide hope .
And , as a doctor , that ’ s the way I come to this .
I ’ m speaking now to the American people as @ @ @ @ @ @ @ that part of me has not left .
Just look at the way the American people have responded to our calls for mitigation , for social distancing .
The American people have great resiliency , and I ’ m so incredibly proud of how the American people have responded .
As the President mentioned , he asked us to be aggressive , to break down barriers to innovation , and to accelerate the development of lifesaving treatments .
And we ’ re doing that at the FDA .
The FDA is committed to @ @ @ @ @ @ @ , but let me make one thing clear : FDA ’ s responsibility to the American people is to ensure that products are safe and effective and that we are continuing to do that .
Our folks — and they ’ re tremendous professionals — are working day and night to do this .
You just can ’ t even imagine how much they ’ re working to provide this support for the American people and I thank them .
Since early January , long before the first domestic case , FDA began @ @ @ @ @ @ @ also want to note that we stood up an incident command group and had been focused on the coronavirus since the very beginning of this public health emergency .
This is , in addition , an all-of-government and all-of-America approach and I ’ ll describe what I mean by that , in terms of the development of therapeutics .
An important part of that work is expanding the potential therapeutic options associated with coronavirus , and we ’ ve learned from our colleagues across the globe about this .
But I want to @ @ @ @ @ @ @ a cancer researcher before all this , and one thing I know about this great country of ours is that we have unbelievable innovators .
We have people who , every day , it ’ s their job to develop treatments for all sorts of diseases .
We are incredibly blessed , as a country , to have this .
And as is true in any illness , these great American innovators — academia , private sector — they have engaged us about the best possible treatment options .
We are looking at @ @ @ @ @ @ @ desks as possible treatment options for coronavirus , and we ’ re extremely encouraged by the interest and the promise that we ’ ve seen from these great American innovators .
Now , again , we need to look at it .
We need the data , we need the information to make the absolute best decisions for the American people .
But I want to assure you , we have over 17,000 people at FDA who are doing this every day .
We need — we need to make sure that these @ @ @ @ @ @ @ get the right drug to the right patient at the right dosage at the right time .
As an example , we may have the right drug , but it may not be in the appropriate dosage form right now , and that may do more harm than good .
Those are the things that that ’ s our job to look at .
And that ’ s why it ’ s really important we have these dedicated professionals looking at these aspects of therapeutic development .
At the same time , we @ @ @ @ @ @ @ to actually get drugs into the hands of providers and patients .
The President mentioned this , but one of the mechanisms is called compassionate use .
Let me just tell you about this .
If there ’ s an experimental drug that ’ s potentially available , a doctor could ask for that drug to be used in a patient .
We have criteria for that and very speedy approval for that .
The important thing about compassionate use — and that ’ s what the President meant , “ This is @ @ @ @ @ @ @ is that we get to collect the information about that .
Because one of the things that I ’ ll promise the American people is we will collect the data and then make the absolute right decisions based upon those data about the safety and efficacy of the treatments .
We are working expeditiously , and we are working to make sure that these products are as safe and effective as they possibly can be .
Let me tell you about a few things that we ’ re currently working on .
And @ @ @ @ @ @ @ with many of the people at this table , our infectious disease experts on the task force .
In the short term , we ’ re looking at drugs that are already approved for other indications .
So they ’ re already approved , as the President said , for other diseases .
As an example , many Americans have read studies and heard media reports about this drug , chloroquine , which is an anti-malarial drug .
It ’ s already approved , as the President said , for the treatment of @ @ @ @ @ @ @ condition .
That ’ s a drug that the President has directed us to take a closer look at , as to whether an expanded-use approach to that could be done to actually see if that benefits patients .
And again , we want to do that in the setting of a clinical trial — a large , pragmatic clinical trial — to actually gather that information and answer the question that needs to be answered and — asked and answered .
Let me give you another example : There ’ s a @ @ @ @ @ @ @ .
This is a pretty exciting area .
And again , this is something that we have given assistance to other countries with as this crisis has developed .
So FDA has been working for some time on this .
If you ’ ve been exposed to coronavirus and you ’ re better and you don ’ t have the virus in your blood , we could collect the blood .
Now , this is a possible treatment ; this is not a proven treatment — just want to emphasize that .
Collect @ @ @ @ @ @ @ have the ability , once it ’ s pathogen-free — that is , virus-free — to be able to give that to other patients .
And the immunoglobulins — the immune response — could potentially provide a benefit to patients .
It ’ s another thing that we ’ re looking at .
Over the next couple weeks , we ’ ll have more information on that .
We ’ re really pushing hard to try to accelerate that .
That ’ s in the sort of more medium- and short-term .
And @ @ @ @ @ @ @ other therapies that will take us three to six months to develop .
And this is a continuous process .
There is no beginning and end to each of this .
This is — you know , we ’ re pushing this through .
The other great thing about the great innovators of America is some of them tell us it ’ s taken us years — years — to develop therapies .
They ’ re looking at pushing that to the months period of time .
And we ’ re trying to @ @ @ @ @ @ @ flexibility , but , at same time , the scientific oversight to make sure that gets done in the best way possible for the American people .
The President mentioned that there is a vaccine trial currently being performed .
It ’ s a phase-one trial , so it ’ s the earliest study that gets done .
We expect that to take 12 months to get to completion — to actually a time where we could approve a vaccine .
But that ’ s — these are all things to bridge to @ @ @ @ @ @ @ vaccine .
It ’ s exciting work .
And the President is right : This is record time for the development of a vaccine and impressive public-private partnership .
The FDA ’ s efforts to facilitate the development of these products are focused on ensuring timely access , while also meeting the agency ’ s world-respected gold standard , relying on strong data from clinical trials to determine if an experimental or an off-the-shelf drug that ’ s used for something else can safely and effectively treat patients .
We want to assure @ @ @ @ @ @ @ hands on deck , as the President mentioned — these efforts — and continue to work with interested sponsors to help expedite the work .
We remain steadfast in helping to foster the development of safe and effective therapies for COVID-19 .
Thank you .
( transcript )

During the task force briefing President Trump announced authorizing to the FDA to relax regulationsto speed up clinical trials for several anti-viral remedies to treat coronavirus. Specifically citing a therapudic drug known as chloroquine President Trump noted trials are underway and could be made available for treatment “almost immediately.”
Now, a drug called chloroquine — and some people would add to it “hydroxy-.” Hydroxychloroquine. So chloroquine or hydroxychloroquine. Now, this is a common malaria drug. It is also a drug used for strong arthritis. If somebody has pretty serious arthritis, also uses this in a somewhat different form.
FDA commissioner Stephen Hahn told reporters scientists still have to conduct clinical trials to see if chloroquine, hydroxychloroquine, and several other anti-viral medications are effective against coronavirus. However, since chloroquine and hydroxychloroquine are already FDA approved to treat malaria & arthritis, they could be used to treat other conditions, including coronavirus, in an “off label” basis.
DR. HAHN: So, before the President nominated me and I was confirmed as Commissioner for Food and Drugs, I was a cancer doctor. And I’ve sat across from countless number of patients and had to talk to them about their diagnosis and their treatment. And one thing that was really important is to provide hope. I have great hope for how we’re going to come out of this situation.
What’s also important is not to provide false hope, but to provide hope. And, as a doctor, that’s the way I come to this. I’m speaking now to the American people as Commissioner of Food and Drugs, but that part of me has not left. Just look at the way the American people have responded to our calls for mitigation, for social distancing. The American people have great resiliency, and I’m so incredibly proud of how the American people have responded.
As the President mentioned, he asked us to be aggressive, to break down barriers to innovation, and to accelerate the development of lifesaving treatments. And we’re doing that at the FDA.
The FDA is committed to continuing to provide regulatory flexibility and guidance, but let me make one thing clear: FDA’s responsibility to the American people is to ensure that products are safe and effective and that we are continuing to do that.
Our folks — and they’re tremendous professionals — are working day and night to do this. You just can’t even imagine how much they’re working to provide this support for the American people and I thank them.
Since early January, long before the first domestic case, FDA began working in collaboration with CDC. I also want to note that we stood up an incident command group and had been focused on the coronavirus since the very beginning of this public health emergency. This is, in addition, an all-of-government and all-of-America approach and I’ll describe what I mean by that, in terms of the development of therapeutics.
An important part of that work is expanding the potential therapeutic options associated with coronavirus, and we’ve learned from our colleagues across the globe about this. But I want to focus on one thing: I was a cancer researcher before all this, and one thing I know about this great country of ours is that we have unbelievable innovators. We have people who, every day, it’s their job to develop treatments for all sorts of diseases. We are incredibly blessed, as a country, to have this.
And as is true in any illness, these great American innovators — academia, private sector — they have engaged us about the best possible treatment options. We are looking at everything that’s coming across our desks as possible treatment options for coronavirus, and we’re extremely encouraged by the interest and the promise that we’ve seen from these great American innovators.
Now, again, we need to look at it. We need the data, we need the information to make the absolute best decisions for the American people. But I want to assure you, we have over 17,000 people at FDA who are doing this every day.
We need — we need to make sure that these — this sea of new treatments will get the right drug to the right patient at the right dosage at the right time. As an example, we may have the right drug, but it may not be in the appropriate dosage form right now, and that may do more harm than good. Those are the things that that’s our job to look at. And that’s why it’s really important we have these dedicated professionals looking at these aspects of therapeutic development.
At the same time, we’re also working through different mechanisms to actually get drugs into the hands of providers and patients.
The President mentioned this, but one of the mechanisms is called compassionate use. Let me just tell you about this. If there’s an experimental drug that’s potentially available, a doctor could ask for that drug to be used in a patient. We have criteria for that and very speedy approval for that.
The important thing about compassionate use — and that’s what the President meant, “This is even beyond Right to Try” — is that we get to collect the information about that. Because one of the things that I’ll promise the American people is we will collect the data and then make the absolute right decisions based upon those data about the safety and efficacy of the treatments.
We are working expeditiously, and we are working to make sure that these products are as safe and effective as they possibly can be. Let me tell you about a few things that we’re currently working on. And this is a plan that was developed with many of the people at this table, our infectious disease experts on the task force.
In the short term, we’re looking at drugs that are already approved for other indications. So they’re already approved, as the President said, for other diseases.
As an example, many Americans have read studies and heard media reports about this drug, chloroquine, which is an anti-malarial drug. It’s already approved, as the President said, for the treatment of malaria, as well as an arthritis condition.
That’s a drug that the President has directed us to take a closer look at, as to whether an expanded-use approach to that could be done to actually see if that benefits patients. And again, we want to do that in the setting of a clinical trial — a large, pragmatic clinical trial — to actually gather that information and answer the question that needs to be answered and — asked and answered.
Let me give you another example: There’s a cross-agency effort about something called convalescent plasma. This is a pretty exciting area. And again, this is something that we have given assistance to other countries with as this crisis has developed. So FDA has been working for some time on this.
If you’ve been exposed to coronavirus and you’re better and you don’t have the virus in your blood, we could collect the blood. Now, this is a possible treatment; this is not a proven treatment — just want to emphasize that. Collect the blood, concentrate that, and have the ability, once it’s pathogen-free — that is, virus-free — to be able to give that to other patients. And the immunoglobulins — the immune response — could potentially provide a benefit to patients. It’s another thing that we’re looking at.
Over the next couple weeks, we’ll have more information on that. We’re really pushing hard to try to accelerate that. That’s in the sort of more medium- and short-term. And that’ll be a bridge to other therapies that will take us three to six months to develop.
And this is a continuous process. There is no beginning and end to each of this. This is — you know, we’re pushing this through.
The other great thing about the great innovators of America is some of them tell us it’s taken us years — years — to develop therapies. They’re looking at pushing that to the months period of time. And we’re trying to provide them the reg- — the regulatory flexibility, but, at same time, the scientific oversight to make sure that gets done in the best way possible for the American people.
The President mentioned that there is a vaccine trial currently being performed. It’s a phase-one trial, so it’s the earliest study that gets done. We expect that to take 12 months to get to completion — to actually a time where we could approve a vaccine. But that’s — these are all things to bridge to the prevention part of this with a vaccine. It’s exciting work. And the President is right: This is record time for the development of a vaccine and impressive public-private partnership.
The FDA’s efforts to facilitate the development of these products are focused on ensuring timely access, while also meeting the agency’s world-respected gold standard, relying on strong data from clinical trials to determine if an experimental or an off-the-shelf drug that’s used for something else can safely and effectively treat patients.
We want to assure the American people that FDA is all hands on deck, as the President mentioned — these efforts — and continue to work with interested sponsors to help expedite the work. We remain steadfast in helping to foster the development of safe and effective therapies for COVID-19. Thank you. (transcript)